Related Experiment Videos
Limb-girdle muscular dystrophy 2C: clinical aspects
M Ben Hamida1, C Ben Hamida, M Zouari
1Institut National de Neurologie, Tunis, Tunisia.
Neuromuscular Disorders : NMD
|December 1, 1996
Summary
Limb-girdle muscular dystrophy type 2C (LGMD2C) presents variably in onset and severity, similar to Duchenne muscular dystrophy. Alpha-sarcoglycan expression also shows significant variability within and between families.
Area of Science:
- Genetics and Molecular Biology
- Neurology
- Biochemistry
Background:
- Limb-girdle muscular dystrophy type 2C (LGMD2C) is an autosomal recessive disorder.
- It is associated with a deficiency in a 35 KDa dystrophin-associated glycoprotein.
- LGMD2C shares clinical similarities with Duchenne muscular dystrophy.
Purpose of the Study:
- To investigate the clinical and molecular variability of LGMD2C.
- To examine the expression patterns of alpha-sarcoglycan in LGMD2C patients.
Main Methods:
- Clinical assessment of patients with LGMD2C.
- Analysis of muscle biopsy samples.
- Evaluation of alpha-sarcoglycan expression.
Main Results:
- LGMD2C exhibits considerable variability in age of onset, disease progression, and muscle biopsy findings.
- Significant variability in alpha-sarcoglycan expression was observed within sibships and across different families.
Conclusions:
- The clinical presentation and alpha-sarcoglycan expression in LGMD2C are highly variable.
- This variability underscores the complex genetic and phenotypic heterogeneity of LGMD2C.